Loading...
•
Dec 31, 2023
Hims & Hers Q4 2023 Earnings Report
Hims & Hers reported a profitable Q4 2023 with revenue growth and subscriber increase.
Key Takeaways
Hims & Hers Health, Inc. reported strong Q4 2023 financial results, with a 47% increase in revenue to $246.6 million and a net income of $1.2 million. The company also saw a 48% year-over-year increase in subscribers, reaching 1.5 million. Adjusted EBITDA was $20.6 million for the quarter.
Revenue increased by 47% year-over-year to $246.6 million.
Net income was $1.2 million, a significant improvement from the previous year's net loss of $(10.9) million.
Subscribers grew to 1.5 million, representing a 48% increase year-over-year.
Adjusted EBITDA reached $20.6 million, compared to $3.9 million in the same quarter of the previous year.
Revenue by Segment
Forward Guidance
Hims & Hers provided revenue and Adjusted EBITDA guidance for Q1 2024 and full year 2024.
Positive Outlook
- Q1 2024 revenue is expected to be between $267 million and $272 million.
- Q1 2024 Adjusted EBITDA is projected to be between $22 million and $27 million.
- Full year 2024 revenue is anticipated to be in the range of $1.17 billion to $1.20 billion.
- Full year 2024 Adjusted EBITDA is expected to be between $100 million and $120 million.
- Adjusted EBITDA margin for the full year 2024 is projected to be 9% to 10%.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...